Background {#Sec1}
==========

Spirulina is a commercial well known micro algae, which contains various antioxidants, especially phycocyanin. Apart from being sold as a nutraceutical, Spirulina is incorporated as a functional ingredient in food products and beverages. Spirulina refers to the dried biomass of *Arthrospira platensis*, belonging to the family *Phormidiaceae*, an oxygenic photosynthetic bacterium found worldwide in fresh and marine waters \[[@CR1]\]. This algae represents an important staple diet in humans and has been used as a source of protein and vitamin supplement in humans without any significant side-effects. Apart from the high (up to 70 %) content of protein, it also contains vitamins, especially B~12~ and provitamin A (β-carotenes) and minerals especially iron. It is also rich in phenolic acids, tocopherols and gamma linolenic acid (GLA) \[[@CR2], [@CR3]\].

Many commercial methods are available for producing gamma linolenic acid (GLA) concentrates include winterization, fractional distillation, urea-inclusion, high performance liquid chromatography and argentated silica gel chromatography \[[@CR4]--[@CR7]\]. Even though GLA concentrates mentioned above are sufficient for most applications; however pharmaceutical applications of GLA require higher concentrations of GLA, often in excess of 90 % but many of these methods did not produce the satisfied output \[[@CR8]\]. Hence new method for producing higher concentrations of gamma linolenic acid and its ester forms from *Spirulina platensis* are urgently needed. Lung cancer is one of the leading causes of cancer deaths (15 %) in the world and is by far the most common cancer in the western world. Globally lung cancer is responsible for more deaths annually than those due to breast cancer, colorectal cancer, and prostate cancer combined together \[[@CR9]--[@CR11]\]. As per the National Institute of Health Analysis (NIH) report, the medical expenditure for the diagnosis and treatment of cancer could be as high as \$ 207 billion, out of which \$ 12 billion could be only for the treatment of lung cancer \[[@CR12]\].

A number of investigations have demonstrated that, a variety of modified fatty acid analogues are promising molecules in cancer prevention and have potential in the treatment of cancer \[[@CR13], [@CR14]\]. Some studies have shown that GLA can slow or stop the growth of some types of cancer cells in tissue cultures in the laboratory. The same kinds of studies suggest that GLA may help some cancer drugs to work better \[[@CR15]--[@CR18]\]. However, there is very little evidence as yet that GLA work to prevent or treat cancers in humans. Human studies are under way to evaluate the role of GLA and other essential fatty acids on the growth of cancer. As existing anticancer drugs of synthetic origin are having more adverse effects, the developments of safe compounds are urgently needed. In recent years, more importance has been given to nutraceuticals/functional foods because they can provide physiological benefits additional to nutritional and energetic, as for instance antihypertensive and anticancer activities. Since the gamma linolenic acid has come under the category of Nutraceuticals/functional foods, its exploration in the treatment of lung cancer may be considered as safe. Considering all these facts, the present research is aimed to produce the high concentrates of methyl gamma linolenate from *Spirulina platensis* using flash chromatography as a molecular target towards treatment of lung cancer and the isolated product is characterized by using HPTLC, NMR and mass spectra. The characterized molecule is subjected to *in*-*vitro* cytotoxic studies on human lung carcinoma A-549 cell lines.

Methods {#Sec2}
=======

General {#Sec3}
-------

All chemicals used were purchased from Fluka chemicals. Their purity was checked by GC. All solvents were purified by distillation using Rotavap (Buchi R120) and if necessary residual water was removed. The components of solvents and elements are given in volume ratios of the components. Methyl gamma linolenate was isolated and purified by using Isolera Flash chromatography System (Biotage INC) and identified using different spectral and HPTLC techniques. The standard methyl gamma linolenate and routine were purchased from Sigma-Aldrich uses thin layer chromatography. The ^1^H NMR and ^13^C NMR were recorded on Bruker DRX-300 (300 MHz FT-NMR) using deuterated chloroform as solvent and TMS as internal standard. The mass spectra of compounds were recorded on JEOL GCMATE II GC-MS.

Algae {#Sec4}
-----

Fresh cultures of *Spirulina platensis* were obtained from Antenna Research Foundation Pvt Ltd., "Madurai, Tamilnadu, India". The cell paste was lyophilized and stored at −20 °C for further use.

General procedure for isolation of methyl gamma linolenate {#Sec5}
----------------------------------------------------------

The Isolera system is a high-performance flash chromatography system, consisting of the following integrated components:

### Isolera flash chromatography system {#Sec6}

A touch screen display, which is a solvent-resistant, color LCD screen with a resolution of 800 × 600 pixels. It serves both as a display and as the system's input device via on-screen touch controls. A fraction collector, which collects fractions into a wide variety of collection racks and vessels. A pump module, which directs liquid flow through the system. A default flow rate is specified for each cartridge but, if desired, the flow rate can be changed. If the flow rate is increased, the system will start the run at the default flow rate and then regulate towards the flow rate defined in the method. The system regulates on both flow rate and pressure. If 90 % of the maximum allowed pressure is reached before the defined flow rate, the flow rate at 90 % pressure will be used. An internal detector, which provides the system with information on the light absorbance of the solvents and samples passing through the detector flow cell. The different fractions can be collected through a automated fraction collector based on the R~f~ the compound of interest can be identified and pooled together after performing thin layer chromatography analysis.

### Preparation of fatty acid methyl esters (FAME) {#Sec7}

Freeze dried biomass of *Spirulina platensis* (50 g) was extracted by reflux for 4 h using a mixture of methanol and acetyl chloride (95:5, 800 ml). The extract obtained was diluted with water and extracted thrice with equal volume of n-hexane containing 0.01 % butylated hydroxyl toluene. The combined n-hexane layer was evaporated to get the fatty acid methyl ester (FAME).

### Enrichment of FAME for methyl gamma linolenate (GLA-ME) {#Sec8}

The FAME obtained was subjected to urea complexation as described previously to remove the saturated fatty acids from the polyunsaturated fatty acids. For the urea complexation, methanol (9 ml) and urea (3 g) were added to FAME. The mixture was heated to get a clear solution. It was cooled at room temperature and stored at 0 °C overnight. Then it was filtered to remove the crystals settled at the bottom. The filtrate was extracted with n- hexane containing 0.01 % butylated hydroxyl toluene. The n-hexane fraction was evaluated for the presence of GLA methyl ester by HPTLC.

### Quantification of GLA-ME in enriched GLA fraction by HPTLC {#Sec9}

#### Preparation of sample solution {#FPar1}

Whole enriched GLA-ME fraction (122.5 mg) was dissolved in 10 ml of n-hexane. This solution was used for application on to the TLC plate.

#### Preparation of standard solution {#FPar2}

Standard GLA-ME was prepared by dissolving 27 mg of GLA-ME and in 10 ml of methanol in a volumetric flask.

#### Chromatographic conditions {#FPar3}

Stationary phase : Silica gel 60 F 254

Mobile phase : Hexane: Acetone (6:4)

Mobile phase volume : 10 ml

Band length : 6 mm

Application rate : 10 s/μl

Development chamber : Camag twin trough development chamber (10 × 10 cm)

Development distance : 6 cm from the application position

Scanner : Camag TLC scanner III

Detection wavelength : 235 nm

Slit dimension : 4.00 × 0.30 mm

Scanning speed : 20 mm/s

Data resolution : 100 μm/step

Measurement mode : Absorption

Peak area of GLA-ME standard = 1379.2

Peak area of GLA-ME in sample = 3605.6

The amount of GLA-ME was quantified by the following formula;$$\documentclass[12pt]{minimal}
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### Separation of GLA-ME using flash chromatography system {#Sec10}

0.5 g of enriched GLA fraction obtained above was directly applied on 10 g samplet and the samplet was dried under vacuum in a rotary evaporator (Buchi R 120). The dried samplet was packed in 50 g KPSil Biotage SNAP Cartridge. A flash chromatography method was developed based on HPTLC profile. A constant flow rate 50 ml/min of mobile phase (60 % hexane: 40 % acetone) is used. A total no of 105 fractions, each 22 ml was collected in different test tubes at the wavelength of 254 nm. Each individual fraction was subjected to TLC Analysis using the above mobile phase in comparison with that of standard methyl gamma linolenate. Fraction no 6--17 was found to be as methyl gamma linolenate and was pooled together. The percentage purity of isolated methyl gamma linolenate was determined using HPTLC (Fig. [1](#Fig1){ref-type="fig"}) and it was confirmed by mass spectral analysis (Fig. [2](#Fig2){ref-type="fig"}), ^1^H NMR (Fig. [3](#Fig3){ref-type="fig"} and ^13^C NMR (Fig. [4](#Fig4){ref-type="fig"}) analysis. The chemical structure and the flash chromatography report for the separation of GLA-ME are given in Fig. [5](#Fig5){ref-type="fig"} and Fig. [6](#Fig6){ref-type="fig"} respectively.Fig. 1HPTLC Chromatogram of GLA- MEFig. 2Mass spectra of GLA-MEFig. 3^1^H NMR of GLA-MEFig. 4^13^C NMR of GLA-MEFig. 5GLA-MEFig. 6Flash Chromatogram of GLA- ME ISOLATION

Characterization of GLA-ME {#Sec11}
--------------------------

FAB-MS: 292 (M, 100 %): 254.70 \[^+^(CH~2~)~4~CH = CHCH~2~CH = CH (CH~2~)~4~COOCH~3~\] *m/z* + 1, 178.82 \[CH~3~(CH~2~)~4~CH = CHCH~2~CH = CHCH~2~CH = CH^+^\],151.69 \[CH~3~(CH~2~)~4~CH = CHCH~2~CH = CHCH~2~CH^+^\] *m/z* + 1, 121.90 \[CH3(CH2)4CH = CHCH2CH^+^\] *m/z*-3. .

^1^H NMR (300 Mhz,CDCl~3~ δ~H~); 5.5 (m, 6H, olefinic C~6~, C~7~, C~9~,C~10~,C~12~,C~13~), 3.7 (s, 3H, CH~3~ ester C~19~), 2.6 (t, 4H, CH~2~ between double bonds C~8~,C~11~), 2.3 (t, 2H, CH~2~ adjacent to C = O, C~17~), 2.1 (m, 4H, CH~2~ adjacent to double bond C~5~,C~14~), 1.7 (m, 8H, C~3~, C~4~, C~15~ and C~16~) 1.3 (m, 2H, CH~2~ next to CH~3~ C~2~), 0.9 (t, 3H, CH~3~ terminal C~1~) ppm

^13^CNMR (300MHZ,CDCl~3~ δ~C~): 14.14- C~1~, 22.53- C~2~, 24.55 -- C~8~, 24.75 - C~11~, 25.60 -- C~16~, 26.85 -- C~5~, 27.18 - C~14~, 29.21- C~15~, 29.23 -- C~4~, 31.72- C~17~, 33.83- C~3~, 51.51- C~19~, 127.56 -- C~7~, C~12~, 129.55 -- C~9~, C~10~, 130.41 -- C~6~, C~13~, 174.82 -- C~18~.

Biological screening {#Sec12}
--------------------

### Cell lines and culture medium {#Sec13}

A-549 cell cultures used in the experiments were procured from National Centre for Cell Sciences, Pune, India. A-549 cells were grown in Earl's Minimal Essential Medium supplemented with 2 mmol L-glutamine, 10 % Fetal Bovine Serum, Penicillin (100 μg/ml), streptomycin (100 μg/ml) and amphotericin B (5 μg/ml) and the cells were maintained at 37 °C in a humidified atmosphere with 5 % CO~2~ and subculture twice a week.

### *In-vitro* apoptosis inducing effect {#Sec14}

The total cell protein content was determined by sulphoradamine B (SRB) assay \[[@CR19]\]. The monolayer cell culture was trypsinized and the cell count adjusted to 1.0 x 10^5^ cell/ml using medium (MEM) containing 10 % newborn calf serum. To each well of the 96 well microtitre plate, 0.1 ml of diluted cell suspension (approximately 10,000 cells) was added. After 24 h, when a partial monolayer was formed, the supernatant was flicked off, the monolayer was washed once and 100 μL of the medium and the culture was exposed to different concentrations of drugs (Table no.1) in microtitre plates. The plates were then incubated at 37 °C for 3 days in 5 % CO~2~ atmosphere, and microscopic examination was carried out and observations recorded every 24 h. After 72 h, 25 μL of 50 % trichloro acetic acid was added to the wells gently such that it forms a thin layer over the drug solution to give an overall concentration of 10 %. The plates were incubated at 4 °C for one hour. The culture plates were flicked and washed five times with tap water to remove traces of medium, drug and serum, and were then air-dried. The air-dried plates were stained with SRB for 30 min. The unbound dye was then removed by rapidly washing four times with 1 % acetic acid. The plates were then air-dried.100 μL of 10 mM Tris base was then added to the wells to solubilise the dye. The plates were shaken vigorously for 5 min. The absorbance was measured using the micro plate reader at a wavelength of 540 nm \[[@CR20]\]. The percentage growth inhibition was calculated using the formula below.$$\documentclass[12pt]{minimal}
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Results and discussion {#Sec15}
======================

The fatty acid methyl esters (FAME) were prepared from the freeze dried biomass of *Spirulina platensis.* The FAME fraction was subjected to urea fractionation for gamma linolenic acid methyl ester by extraction with n-hexane. This hexane fraction was named as enriched GLA-ME fraction. It was quantified by using HPTLC and was found to contain 57.62 % w/w of GLA-ME. HPTLC method has been developed first time, since already developed methods like gas Chromatography and reverse phase HPLC are tedious and expensive compared to HPTLC which has been proven equal to GC and reverse phase HPLC statistically. The fraction was then directly applied to flash chromatography using hexane: acetone (60:40) as mobile phase. Methyl gamma linolenate was isolated as viscous pale yellow oil (yield 71 % w/v). The spectral analysis. such as mass spectra, ^1^H NMR and ^13^C NMR were consistent with the assigned structure of GLA-ME. The compound was screened for cytotoxicity activity against A-549 cells by determination of CTC~50~ (concentration of the sample required to kill 50 % of the cells) value by SRB assay. The experiments, each were carried out each in triplicate and the results are tabulated in Table [1](#Tab1){ref-type="table"} and compared with the standard drug Rutin (Fig. [7](#Fig7){ref-type="fig"}), a bioflavanol which is a well established promising anticancer agent and its mechanism may be due to the induction of apoptosis \[[@CR21]\]. The compound is found to possess comparable cytotoxicity as the standard. However, further detailed investigations on *in-vivo* studies are needed to explore its potential.Table 1Determination of cytotoxicity by SRB methodS. No.CompoundConcentration (μM% Growth InhibitionCTC~50~1GLA ME3.33397.450.46821.66686.3930.83372.3840.41648.455RUTIN3.33398.650.44261.66688.4170.83375.2580.41649.05CTC~50~-concentration of the sample required to kill 50 % of the cellFig. 7*In-vitro* cytotoxic studies □ GLA-ME, Δ- Standard Rutin

The novel method has been developed for the isolation of GLA-ME by using a flash chromatography system which improved the percentage yield up to three folds (71 %) in comparison with the conventional methods (18-20 %). The cytotoxicity shown by GLA-ME may be due to the induction of apoptosis of tumor cells by augmenting free radical generation only in the tumor cells but not normal cells. It is evidenced by the research work carried out by Undurti *et al.* \[[@CR22]\]. They also reported that induction of apoptosis of tumor cells by GLA is due to its action at the gene/oncogene level and by altering *BCl-2* expression. Hence, it may be concluded the cytotoxicity shown by GLA-ME may be due to induction of apoptosis effect. However, a detailed study of this mechanism is in progress.

Conclusion {#Sec16}
==========

Methyl gamma linolenate was isolated from the *Spirulina platensis* by flash chromatography system and the percentage yield is found to be 71 %. It may be concluded that the Flash chromatography system plays a major role in improving the yield for the isolation of methyl gamma linoleate from *Spirulina platensis*. Since the process consumes very less time compared to conventional isolation, many chemists searching for new technologies for the production of plant constituents of medicinal interest can adopt this method. The isolated molecule is a potent cytotoxic agent towards human lung carcinoma cell lines, it may be further taken up for extensive study.
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